NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Cerulean Associates, LLC

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

John Avellanet to Speak at International Contract Pharma Conference on Supplier Management - John Avellanet, Managing Director of Cerulean Associates, will be helping kick off the 2nd day of the international 7th Annual Contract Pharma Contracting and Outsourcing Conference, to be held in New Brunswick, New Jersey on Friday, September 26th
John Avellanet to Speak at International Contract Pharma Conference on Supplier Management

 

NewswireTODAY - /newswire/ - Williamsburg, VA, United States, 2008/09/01 - John Avellanet, Managing Director of Cerulean Associates, will be helping kick off the 2nd day of the international 7th Annual Contract Pharma Contracting and Outsourcing Conference, to be held in New Brunswick, New Jersey on Friday, September 26th.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Williamsburg-based John Avellanet, Managing Director of Cerulean Associates, will be helping kick off the 2nd day of the international 7th Annual Contract Pharma Contracting and Outsourcing Conference, to be held in New Brunswick, New Jersey on Friday, September 26th.

The Conference covers supplier topics critical to pharmaceutical, biotechnology and medical device executives, and includes top speakers from the US Food and Drug Administration (FDA) and industry. Topics include risk-based supplier management programs, FDA inspection issues, global outsourcing trends, and best practices for handling global supply chains. More information about the conference can be found on the web at: contractpharma.com/2008conference.

Mr. Avellanet will be discussing best practices for designing a risk-based supplier selection and vendor qualification program based on his own experiences and those of his clients.

Later this month, Mr. Avellanet will be speaking to the Management Roundtable on how to prevent contractors and outsourced partners stealing trade secrets (September 10), providing an update on the FDA’s revised Part 11 and EU’s Annex 11 as the guest of an FDA Expert Briefing (September 18), and speaking to the Virginia Commonwealth University business school on the role of IT in regulatory compliance (September 20).

John Avellanet is an internationally recognized expert, speaker and syndicated author on cost-effective compliance and quality systems, including computer and records management compliance. A former C-level executive for a Fortune 50 combination device and biotechnology subsidiary, he writes and publishes the monthly executive newsletter, SmarterCompliance™. In 2006, he founded his independent consulting firm, Cerulean Associates, LLC.

Cerulean Associates, LLC (ceruleanllc.com) is a small, private compliance consulting company that helps clients achieve cost-effective lean compliance, quality by design, faster time to market and prevent trade secret theft.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Cerulean Associates, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


John Avellanet to Speak at International Contract Pharma Conference on Supplier Management

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: John Avellanet - CeruleanLLC.com 
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Cerulean Associates, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Cerulean Associates, LLC / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab & hyaluronidase-nvhy) Injection
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1
SCHOTT Pharma Unveils Innovative Nest Design for Ready-to-use Cartridges
Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-class MAIT Cell Engager in Immuno-oncology
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry through Consistent Quality Assurance, On-time Delivery
Bylvay® (odevixibat) Data Shows Sustained Improvement in Severe Itch and Serum Bile Acid Levels in Patients with PFIC and ALGS
Genome BC, STEMCELL Technologies and UBC Partner to Accelerate the Ability to Develop Stem Cells
PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with its Microarray Detection Platform
BASF Partners with Acies Bio to Drive Sustainable Production of Personal and Home Care Ingredients
Ipsen’s Kayfanda® (odevixibat) Approved in European Union for Cholestatic Pruritus in Alagille Syndrome, A Rare Liver Disease
STEMCELL Technologies and Axion BioSystems Partner to Streamline Culture and Analysis of Excitable Cells
Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value
BASF Declares Force Majeure for Selected Vitamin A, Vitamin E, and Carotenoid Products As Well As Selected Aroma Ingredients
Ono Pharmaceutical Co., Ltd Enters into A New Option and Research Collaboration Agreement with Monash University
Aragen Life Sciences Ltd Receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2005-2025 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)